Science Will Win Season 1 - What’s Next For Gene Therapy?

Gene therapy is at a pivotal moment. For eligible rare disease patients, the potential impact could be huge. So how can we support that potential to fruition and what will it mean if we do? In our season finale, host Adam Rutherford and guests take a peek into what a world with successful gene therapies could look like for patients, healthcare and society.
Featuring guests:
-Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders
-Erik Paulsen, Chair, Institute for Gene Therapies
-Karolina Hanslik, Former Senior Project Manager, EURORDIS
-Nikhil Gadre, Senior Director, Global Commercial, Hemophilia Gene Therapy, Pfizer
-Paige Bischoff, Senior Vice President, Global Public Affairs, Alliance for -Regenerative Medicine
-Paolo Morgese, EU Director, Market Access, Alliance for Regenerative Medicine
-Reda Guiha, IDM Regional President, Rare Disease, Pfizer
-Simone Boselli, Director, Public Affairs, EURORDIS
-Tomislav Sokol, Member of European Parliament
SUBSCRIBE to get the latest Science Will Win episodes: • Science Will Win
Listen to Science Will Win on Apple Podcasts: podcasts.apple...
Listen to Science Will Win on Spotify: open.spotify.c...
Visit www.pfizer.com... to hear more.